Moderna, Inc.

SWX:MRNA Stock Report

Market Cap: CHF 20.2b

Moderna Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MRNA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies13,5550.00342%
State or Government321,7460.0811%
Individual Insiders26,377,1496.65%
General Public57,503,16014.5%
Institutions312,570,64978.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 67.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
FMR LLC
45,623,807CHF 2.3b62.8%0.14%
7.47%
BlackRock, Inc.
29,635,876CHF 1.5b-8.83%0.02%
5.76%
Vanguard Capital Management, LLC
22,872,458CHF 1.2b0%0.03%
5.54%
Stéphane Bancel
21,963,357CHF 1.1b0.03%no data
5.04%
Baillie Gifford & Co.
19,985,876CHF 1.0b-2.89%0.65%
4.71%
Capital Research and Management Company
18,697,694CHF 953.2m45.8%0.05%
3.94%
Vanguard Portfolio Management, LLC
15,616,367CHF 796.1m0%0.05%
3.75%
State Street Global Advisors, Inc.
14,861,409CHF 757.6m-9.19%0.03%
2.38%
Geode Capital Management, LLC
9,435,132CHF 481.0m2.34%0.03%
2.29%
Two Sigma Investments, LP
9,086,404CHF 463.2m23.8%0.48%
2.03%
Theleme Partners LLP
8,048,245CHF 410.3m-0.42%19.57%
1.52%
UBS Asset Management AG
6,028,481CHF 307.3m6.21%0.03%
1.28%
Morgan Stanley
5,085,122CHF 259.2m-14.2%0.03%
1.19%
Charles Schwab Investment Management, Inc.
4,734,356CHF 241.3m0%0.04%
1.17%
Flagship Pioneering, Inc
4,632,149CHF 236.1m0%23.22%
1.09%
BNP Paribas Financial Markets SNC
4,317,219CHF 220.1m3.97%0.16%
1.07%
Goldman Sachs Asset Management, L.P.
4,259,648CHF 217.1m51.1%0.05%
1.05%
Invesco Capital Management LLC
4,174,464CHF 212.8m-32.4%0.04%
1.02%
Alyeska Investment Group, L.P.
4,051,185CHF 206.5m25.5%0.66%
0.85%
Eaton Vance Management
3,374,120CHF 172.0m15.2%0.04%
0.74%
Northern Trust Global Investments
2,952,041CHF 150.5m-1.68%0.02%
0.69%
Banque Pictet & Cie SA
2,748,754CHF 140.1m-12.2%1.85%
0.68%
Norges Bank Investment Management
2,702,832CHF 137.8m0%0.01%
0.6%
First Trust Advisors LP
2,392,693CHF 122.0m59.3%0.08%
0.59%
Wellington Management Group LLP
2,357,597CHF 120.2m2,730%0.02%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/17 15:52
End of Day Share Price 2026/07/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Moderna, Inc. is covered by 42 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Eliana MerleBarclays
Huidong WangBarclays